JPS61500767A - エイズに関係するレトロウイルス（ｈｔｌｖ―３）の連続的産生のための方法 - Google Patents

エイズに関係するレトロウイルス（ｈｔｌｖ―３）の連続的産生のための方法

Info

Publication number
JPS61500767A
JPS61500767A JP60501923A JP50192385A JPS61500767A JP S61500767 A JPS61500767 A JP S61500767A JP 60501923 A JP60501923 A JP 60501923A JP 50192385 A JP50192385 A JP 50192385A JP S61500767 A JPS61500767 A JP S61500767A
Authority
JP
Japan
Prior art keywords
cells
htlv
cell
target
infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60501923A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0568232B2 (OSRAM
Inventor
ガロ，ロバート　シー
ポポビツク，ミクラス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of JPS61500767A publication Critical patent/JPS61500767A/ja
Publication of JPH0568232B2 publication Critical patent/JPH0568232B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP60501923A 1984-04-23 1985-04-23 エイズに関係するレトロウイルス（ｈｔｌｖ―３）の連続的産生のための方法 Granted JPS61500767A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/602,946 US4647773A (en) 1984-04-23 1984-04-23 Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
US643729 1984-08-24
US602946 1996-02-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP5034673A Division JP2686892B2 (ja) 1984-04-23 1993-01-29 エイズに関係するレトロウイルス（ｈｔｌｖ−ｉｉｉ）の連続的産生のための細胞株

Publications (2)

Publication Number Publication Date
JPS61500767A true JPS61500767A (ja) 1986-04-24
JPH0568232B2 JPH0568232B2 (OSRAM) 1993-09-28

Family

ID=24413413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60501923A Granted JPS61500767A (ja) 1984-04-23 1985-04-23 エイズに関係するレトロウイルス（ｈｔｌｖ―３）の連続的産生のための方法

Country Status (3)

Country Link
US (1) US4647773A (OSRAM)
JP (1) JPS61500767A (OSRAM)
ZA (1) ZA853024B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
US5364933A (en) 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) * 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US5112756A (en) * 1986-06-02 1992-05-12 Canadian Patents And Development Limited Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells
US5019557A (en) * 1986-09-15 1991-05-28 Pitts Jr Ferris N Method for the effective treatment of disease conditions in humans associated with HTLV-III infection
US5118602A (en) * 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
WO1993024617A1 (en) * 1992-05-28 1993-12-09 Medical College Of Wisconsin Human virus associated with chronic fatigue immune deficiency syndrome (cfids) and assay therefor
DK1486211T3 (da) * 1993-04-30 2009-01-19 Wellstat Biologics Corp Sammensætninger til behandling af cancer ved anvendelse af vira
NZ279855A (en) 1994-02-04 1998-05-27 Bio Merieux Msrv1 and msrv2 pathogenic and/or infectious agents associated with ms, nucleic acids encoding them and diagnostic and therapeutic applications
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
WO1995025789A1 (en) * 1994-03-22 1995-09-28 The Immune Response Corporation Highly efficient production and isolation of viral particles
FR2737500B1 (fr) * 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
EP0942987B1 (en) * 1996-11-26 2009-08-19 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146512A (ja) * 1982-02-25 1983-09-01 Kouchi Ika Daigaku ヒトｃ型ウイルス（白血病ウイルス）産生細胞株（ｍｔ−２）およびその培養樹立方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146512A (ja) * 1982-02-25 1983-09-01 Kouchi Ika Daigaku ヒトｃ型ウイルス（白血病ウイルス）産生細胞株（ｍｔ−２）およびその培養樹立方法

Also Published As

Publication number Publication date
JPH0568232B2 (OSRAM) 1993-09-28
US4647773A (en) 1987-03-03
ZA853024B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
KR910003916B1 (ko) 후천성 면역 결핍증후군(aids)과 관계가 있는 레트로 비루스(htlv-iii)의 연속적인 생산을 위한 방법과 셀라인
Popovic et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
Montagnier et al. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines
JPS61500767A (ja) エイズに関係するレトロウイルス（ｈｔｌｖ―３）の連続的産生のための方法
CA1272454A (fr) Retrovirus associe aux lymphadenopathies et adapte a des lignees continues de cellules lymphoblastoides b, capables de produire en continu ledit retrovirus et procede pour leurobtention
HINO et al. Mother-to-child transmission of human T-cell leukemia virus type-I
Wang et al. Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus.
Miyoshi et al. Natural infection in non‐human primates with adult T‐cell leukemia virus or a closely related agent
Casareale et al. A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV)
US6395495B1 (en) Methods and kits for detecting antibodies against an HIV variant
EP0260691A2 (en) Immunotherapy for aids patients
US6600023B1 (en) Antibody directed against HIV-1 P25 antigen
US7122188B1 (en) Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1
SPERDUTO et al. Increased susceptibility of neonatal monocyte/macrophages to HIV-1 infection
Baes Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
US6428952B1 (en) Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies
JPH02500642A (ja) Ｈｓｂ‐２細胞系統中でのｈｂｌｖウイルスの製造
Lewis et al. Human immunodeficiency virus‐induced pathology favored by cellular transmission and activation
US4792524A (en) Adult T cell leukemia associated cell strain
Getchell et al. Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line
DE3650468T2 (de) Methoden zur Verwendung von an humanen Klasse-II-Histokompatibilitätsantigenen mangelnden Zellinien
WELLS et al. Quantitative Comparison of Epstein‐Barr Virus Receptor Expression on sIgM and sIgG Cell Lines and B‐cell Lymphoma Biopsies
Lange et al. Establishment of a cell line from bovine skin leukosis tumour and detection of retrovirus activities
DK172739B1 (da) Fremgangsmåde og cellelinie til kontinuerlig dannelse af retrovirus (HTLV-III) beslægtet med AIDS
Phillips et al. Type C oncornavirus isolation studies in systemic lupus erythematosus. III. Isolation of a putative retravirus by triple cell fusion.

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term